In this episode of the Gladden Longevity Podcast, Dr. Gladden hosts Joshua Fritzler, President of Olympia Pharmaceuticals, and Nicole Snow to discuss the intricacies of compounding pharmacies, focusing on the differences between 503A and 503B pharmacies, the role of compounding in personalized medicine, and the current landscape of peptides and FDA oversight. The conversation highlights the importance of safety, regulation, and quality assurance in compounded medications, providing listeners with a comprehensive understanding of how these pharmacies operate and their significance in modern healthcare.
For Audience
Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe
If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now
Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!
Takeaways
· Compounding pharmacies create personalized medications not commercially available.
· 503A pharmacies serve individual patients with specific prescriptions.
· 503B pharmacies produce larger batches for clinics and have stricter regulations.
· Compounded medications can be tailored to avoid allergens or intolerances.
· FDA does not approve compounded medications, but regulates the pharmacies.
· Safety profiles of compounded medications are generally high when produced correctly.
· Patients can request specific formulations that are not available commercially.
· Compounding pharmacies must comply with state and federal regulations.
· Quality assurance is critical in compounding, including testing for potency.
· Understanding the differences between compounding pharmacies is essential for patients.
Chapters
00:00 Introduction to Compounding Pharmacies
02:55 Understanding 503A and 503B Pharmacies
05:56 The Role of Compounding in Personalized Medicine
08:52 Safety and Regulation of Compounded Medications
11:54 Differences Between 503A and 503B Pharmacies
14:52 Navigating Prescription and State Regulations
17:50 The Current Landscape of Peptides and FDA Oversight
24:03 Quality Assurance in Compounding Pharmacies
27:55 Conclusion and Future Directions
55:52 A Call for a Manhattan Project in Chronic Disease Research
To learn more about Joshua:
Email: olympia@moburst.com
Website: http://olympiapharmacy.com
LinkedIn: https://www.linkedin.com/in/joshuafritzler/
Reach out to us at:
Website: https://gladdenlongevity.com/
Facebook: https://www.facebook.com/Gladdenlongevity/
Instagram: https://www.instagram.com/gladdenlongevity/?hl=en
LinkedIn: https://www.linkedin.com/company/gladdenlongevity
YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw
